Fenbendazole for Veterinary Use: Products, Species & Regulatory Status

Fenbendazole is a benzimidazole antiparasitic drug used in veterinary medicine. FDA-approved fenbendazole products exist for multiple animal species and in different product and regulatory categories.

That means the word "fenbendazole" by itself does not tell you the intended species, dosage form, strength, approved indication or whether a particular product is over the counter or prescription-only. Those details have to be taken from the exact product labeling.

Veterinary fenbendazole and approved parasite indications

For dogs, FDA-approved fenbendazole products include products labeled for treatment and control of specific gastrointestinal parasites. Current FDA information identifies approved canine indications that include:

  • ascarids, including Toxocara canis and Toxascaris leonina;
  • hookworms, including Ancylostoma caninum and Uncinaria stenocephala;
  • whipworms, including Trichuris vulpis;
  • the tapeworm Taenia pisiformis.

Those indications are product-label claims. They should not be expanded to every parasite or every animal species simply because fenbendazole is used in veterinary medicine.

FDA also lists fenbendazole products for other species, including food-producing animals and certain other animal classes. The applicable label, species, route and regulatory requirements therefore need to be checked for the actual product being considered.

Is fenbendazole OTC or prescription?

There is no single correct OTC-or-prescription answer for every veterinary fenbendazole product.

FDA records for canine fenbendazole provide a clear example. Under NADA 121-473, PANACUR C and SAFE-GUARD Canine are identified as over-the-counter products, while PANACUR Granules 22.2% is identified as a prescription product.

Other fenbendazole products are approved for different species and may have different marketing status, dosage forms or conditions of use. A product should therefore be described as OTC or Rx only after its exact label and approval record are identified.

The same active ingredient can appear in products with different legal and practical requirements.

Product identity matters

When researching a fenbendazole product, useful identifying information includes:

  • active ingredient: fenbendazole;
  • trade or generic product name;
  • intended animal species;
  • dosage form;
  • strength or concentration;
  • route of administration;
  • approved indications;
  • OTC, prescription or other applicable regulatory status;
  • FDA application information on the finished animal drug.

For example, FDA records identify 22.2% fenbendazole granules in canine products, but the regulatory status depends on the particular presentation and labeling. The concentration alone should not be used to assume whether a product is OTC or prescription.

Approved use versus extra-label use

An FDA-approved animal drug has specific labeled species, indications, routes and conditions of use. Use outside those labeled conditions is extra-label use.

Federal law allows certain extra-label animal-drug use by or on the lawful order of a licensed veterinarian when the applicable requirements are met. That is different from an owner independently extending treatment, changing the species, altering the duration or using the product for an unlisted condition.

FDA has specifically warned veterinary professionals about reported cases of bone marrow hypoplasia and pancytopenia in dogs associated with some prolonged extra-label fenbendazole use. In the cases highlighted by FDA, treatment had continued beyond the labeled duration.

This is a reason to keep a clear boundary between labeled product use and veterinarian-directed extra-label therapy. Owners should not prolong treatment or alter the regimen without veterinary direction.

FDA-approved products versus compounded fenbendazole

Compounded animal drugs are not FDA-approved finished products, even when they contain an active ingredient that is also used in an FDA-approved animal drug.

FDA's current animal-compounding materials state that a number of FDA-approved fenbendazole products are available for labeled or legally appropriate extra-label use. FDA has also stated that if a veterinarian determines that a different dosage form, strength or concentration of fenbendazole is medically necessary, a patient-specific prescription may be sufficient for that specialty formulation.

That is a patient-specific compounding context, not evidence that every fenbendazole formulation should be compounded or that an available compounded preparation is equivalent to an FDA-approved product.

Newberry Express Pharmacy identifies Veterinary as one of its compounding service areas. That general service category does not establish that Newberry stocks, dispenses or compounds fenbendazole in any particular formulation.

When veterinary authorization is needed

Whether a veterinarian's prescription or other authorization is required depends on the exact fenbendazole product and intended use.

An OTC canine product can be marketed without a prescription when used according to its approved labeling. A prescription fenbendazole product requires the appropriate veterinarian authorization. Extra-label use and patient-specific compounded formulations involve additional veterinary oversight and should not be treated as equivalent to selecting an OTC product from the shelf.

For food-producing animals, species-specific labeling and withdrawal requirements can also be important and should be followed for the exact approved product.

What to verify before selecting a fenbendazole product

Before relying on a fenbendazole product description, confirm:

  • the animal species on the label;
  • the exact product name;
  • active ingredient and concentration;
  • dosage form and route;
  • approved parasite indications;
  • whether the product is OTC or prescription;
  • whether the intended use is labeled or extra-label;
  • whether a veterinarian has issued a prescription when one is required;
  • FDA approval information for the finished animal drug.

FDA-approved animal drugs normally identify an NADA or ANADA number on the label. That can help distinguish an approved product from a compounded or otherwise unapproved preparation.

Fenbendazole is a legitimate veterinary antiparasitic ingredient, but its product forms and regulatory categories are not interchangeable. The exact species, product, label and veterinary instructions should determine how a particular fenbendazole product is evaluated and used.